Abstract
To investigate the therapeutic effect of dendritic cells pulsed with lysates of heat-treated CT26 colon carcinoma cells. Bone marrow-derived DCs were pulsed with lysates of heat-treated tumor cells and were used to immunize BALB/c mice with established colon carcinoma. Cytotoxic T lymphocyte (CTL) response was detected. The therapeutic effect induced by DCs was observed by tumor weight and survival time. DCs pulsed with lysates of heat-treated tumor cells markedly induced specific cytotoxic activity of CTLs. Tumor growth in the immunized BALB/c mice was significantly inhibited and the survival time of the tumor-bearing mice was prolonged. DCs pulsed with lysates of heat-treated tumor cells have an observable therapeutic effect on established colon carcinoma-bearing mice.
Similar content being viewed by others
References
Gilboa E. DC-based cancer vaccines. J Chin Invest, 2007, 117: 1195–1203 10.1172/JCI31205, 1:CAS:528:DC%2BD2sXlt1Omtrc%3D
Scott E S, Stephen V, Ryan W, et al. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res, 2002, 62: 1884–1889
Jacques B, Beatrice S T, Karolina P, et al. Dendritic cells as vectors for therapy. Cell, 2001, 106: 271–274 10.1016/S0092-8674(01)00448-2
Todryk S M, Eaton J, Birchall L, et al. Heated tumour cells of autologous and allogeneic origin elicit anti-tumor immunity. Cancer Immunol Immunother, 2004, 3: 323–330
Fu G Q, Meng F D, Guo R X, et al. Anti-tumor immune response induced by HSP70 (in Chinese). Cell Mol Immunol, 2002, 18: 393–396 1:CAS:528:DC%2BD3sXntlygsL0%3D
Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med, 1992, 176: 1693–1702 1460426, 10.1084/jem.176.6.1693, 1:STN:280:DyaK3s%2FpsVOktw%3D%3D
Kono K, Akahashi A, Sugai H, et al. Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer. Clin Cancer Res, 2002, 8: 3394–3400 12429626, 1:CAS:528:DC%2BD38XpsVCgt7w%3D
Rougier P, Andre T, Panis Y, et al. Colon cancer. Gastroenterol Clin Biol, 2006, 2: 2S24–2S29
Saif M W. Targeted agents for adjuvant therapy of colon cancer. Clin Colorectal Cancer, 2006, 6: 46–51 16796791, 10.3816/CCC.2006.n.020, 1:CAS:528:DC%2BD28Xnt1Cht7k%3D
He X Z, Wang L, Zhang Y Y. An effective vaccine against colon cancer in mice: Use of recombinant adenovirus interleukin-12 transduced dendritic cells. World J Gastroenterol, 2008, 28:14: 532–540 10.3748/wjg.14.532
John M, Timmer M. Dendritic cell vaccines for cancer immunotherapy. Annual Review of Medicine, 1999, 50: 507–529 10.1146/annurev.med.50.1.507
Frank O, Nestle, Jacques B. Dendritic cells: On the move from bench to bedside. Nature Medicine, 2001, 7: 761–765 10.1038/nm1201-1285
Heiichiro U, Taketoshi Y. Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70. Int Immunol, 2001, 13: 1233–1242 10.1093/intimm/13.10.1233
Massa C, Melani, C, Colombo M P. Chaperon and adjuvant activity of HSP70: different natural killer requirement for cross-priming of chaperoned and bystander antigens. Cancer Res, 2005, 65: 7942–7949 16140966, 1:CAS:528:DC%2BD2MXpslahsrc%3D
Stefan W, Krause, Robert G, et al. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells. Clin Cancer Res, 2004, 10: 3699–3707 10.1158/1078-0432.CCR-03-0683
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the Key Project of Fujian Provincial Scientific Program (Grant No. 2007Y0014)
Rights and permissions
About this article
Cite this article
Ying, M., Zhen, Q., Liu, S. et al. Treatment of established colon carcinoma-bearing mice by dendritic cells pulsed with lysates of heat-treated tumor cells. SCI CHINA SER C 52, 831–835 (2009). https://doi.org/10.1007/s11427-009-0112-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-009-0112-6